CDC says delay of Chiron flu vaccine not a problem

first_imgAug 27, 2004 (CIDRAP News) – Close to half of the nation’s influenza vaccine doses will be shipped later than expected this fall, but everyone who wants a flu shot should ultimately be able to get it, federal health officials said today.Chiron Corp. announced yesterday that it is delaying release of its flu vaccine doses until early October because some lots of vaccine didn’t meet sterility standards. The company said it expects to ship 46 million to 48 million doses, down from the 50 million doses predicted previously.But Julie Gerberding, MD, MPH, director of the Centers for Disease Control and Prevention (CDC), said today the CDC still expects that about 100 million doses of vaccine, more than ever before, will be available this year.”Those who are used to receiving their shot in early October may not get it then,” Gerberding said. But, “The bottom line is that right now we’re expecting to have enough flu vaccine so that everybody who needs flu vaccine can have it. . . . For folks who are trying to plan for their immunization, the best thing is to stay tuned to messages from your local health officers and your clinician.”The other flu vaccine manufacturers are expected to deliver their product on schedule, Gerberding reported. Chiron and Aventis Pasteur are each expected to produce roughly half of the projected 100 million doses, while MedImmune is likely to supply about 1.5 million doses of the intranasal vaccine FluMist, she said.Chiron anticipates shipping 40 million doses in October, and MedImmune also will deliver its doses in October, according to Gerberding. After shipping a few doses this month, Aventis anticipates delivering 15 million to 20 million doses in September and the rest in October, she said.”We’re confident that we’ll be able to get vaccination programs started on time with the doses that we do have,” Gerberding commented.Neither Chiron nor Gerberding revealed exactly what caused the problem with the Chiron vaccine, produced in Liverpool, England. The company announcement said “a small number of lots” failed to meet sterility specifications. “While ongoing internal investigations into the root cause of the variance indicate no widespread issues with the manufacturing process, Chiron has delayed releasing any Fluvirin doses until it has completed additional release tests,” the announcement said.Gerberding said Chiron officials told her they “have identified the problem, they’re fixing it, and they’re taking extra steps to make sure they have a safe product before they ship it.”Chiron said its planned “late-season delivery” of 2 million Fluvirin doses for the CDC stockpile for the Vaccines for Children program remains on schedule. Those doses are in addition to the 46 million to 48 million produced for general distribution.Gerberding said the vaccine lots affected by the sterility problem don’t include any pediatric vaccine. “We’re not expecting a decrease in total predicted doses available for children at this time,” she said.In response to a question, she said Chiron’s vaccine production problems, to her knowledge, were not related to thimerosal, a mercury compound used as a preservative in most flu vaccine doses. The CDC predicted in May that 6 million to 8 million doses of thimerosal-free flu vaccine would be produced this year for people concerned about the preservative.Gerberding said flu vaccine delays are nothing new. “As recently as 2001 we had some shipments that were delayed until October. . . . We’ve been here before, we’ve done this before, and we’ve handled it.”The CDC, she noted, recommends flu vaccination for people aged 50 and older, those who have a chronic medical condition or weakened immunity, those who expect to be pregnant during the flu season, children aged 6 to 23 months, healthcare workers, and people in close contact with others in the foregoing categories.last_img read more

Paris Saint-Germain to lead French soccer fundraising after Notre Dame fire

first_imgThe roof was largely destroyed and the spire collapsed before firefighters brought the fire under control some 15 hours later.Ligue 1 leader PSG has pledged to support both the restoration efforts and the emergency services who battled to extinguish the fire and also ensure a number of valuable artifacts could be saved.”In the aftermath of the fire that ravaged part of the Notre Dame de Paris Cathedral, Paris Saint-Germain shares the immense emotion of all Parisians, the French people and those around the world who have been shocked and saddened by this disaster,” the club said in a statement on Tuesday.”The club has already started to bring together all its key stakeholders, main partners and huge community of fans both in Paris and abroad, aiming to start or participate in a series of initiatives such as fundraising events that will be part of the tremendous campaign to rebuild the cathedral in the following years.”Paris Saint-Germain would also like to express its admiration and solidarity towards the Paris Fire Brigade, whose commitment and bravery made it possible to overcome the flames and limit the extent of the damage. The club will also provide support to the firefighters.” French soccer team Paris Saint-Germain has promised fundraising initiatives to aid the restoration of Notre Dame cathedral after Monday’s fire.The 850-year-old masterpiece sustained extensive damage in the blaze, believed to be accidental, that was discovered toward the center of the structure where renovation work is being carried out. France’s Ligue de Football Professionnel also intends to provide financial support for the repair efforts.”This is help that we will coordinate with all players in French football,” LFP president Nathalie Boy de la Tour said.”We will be in solidarity in this drama, which has touched us all.”The Paris Saint-Germain family will provide long-term support for the reconstruction of Notre-Dame de Paris.For more information: https://t.co/2IRVVtjQi8— Paris Saint-Germain (@PSG_English) April 16, 2019last_img read more